Cencora Boosts FY26 Adjusted EPS Outlook to $17.70-$17.90
summarizeSummary
Cencora has raised its fiscal year 2026 adjusted EPS guidance to a new range of $17.70 to $17.90. This specific update follows the company's Q2 earnings report on May 6, where it had previously announced a general raise in its full-year EPS guidance. The upward revision signals improved financial performance expectations and management's confidence in the company's outlook.
At the time of this announcement, COR was trading at $267.77 on NYSE in the Life Sciences sector, with a market capitalization of approximately $51.6B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.